Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis: Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848)
- 31 December 1993
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 17 (1) , 40-47
- https://doi.org/10.1016/s0168-8278(05)80519-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical ModelJournal of Cardiovascular Pharmacology, 1987
- Effects of Single Doses of the Converting Enzyme Inhibitor Cilazapril in Normal VolunteersJournal of Cardiovascular Pharmacology, 1987
- Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosisThe American Journal of Medicine, 1984
- CAPTOPRIL AND RESISTANT ASCITESThe Lancet, 1983
- CAPTOPRIL AND RESISTANT ASCITES: A WORD OF CAUTIONThe Lancet, 1983
- CAPTOPRIL AND RESISTANT ASCITESThe Lancet, 1983
- Determinants of Drug Disposition in Patients with Cirrhosis†Hepatology, 1983
- Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captoprilThe American Journal of Medicine, 1982
- Drug Pharmacokinetics in Cardiac and Hepatic DiseaseAnnual Review of Pharmacology and Toxicology, 1980
- Characterization of the renin-aldosterone system in decompensated cirrhosis.Circulation Research, 1977